SM
Sunil Malik
About Sunil Malik
Data last updated:
Sunil Malik is a Director at Norbix Pharma Private Limited (since 2023). The companies operate in Pharma. Earlier, Sunil Malik was a Director at Relward Pharma Private Limited (2020–2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Norbix Pharma Private Limited U47721HR2023PTC116998 | Director | 05 Dec 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Relward Pharma Private Limited U24299HR2020PTC090989 | Director | 18 Nov 2020 | 2020 | ₹3.37 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sunil Malik
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankit Raj | 10265451 | Norbix Pharma Private Limited | Director |
| Gurpreet Singh | 10475870 | Norbix Pharma Private Limited | Director |
| Sumit Kumar Pandey | 09116504 | Norbix Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Malik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Malik
Sunil Malik currently holds 1 directorship: Norbix Pharma Private Limited (Director, since 05 Dec 2023).
Sunil Malik was first appointed on 18 Nov 2020 as Director at Relward Pharma Private Limited. The most recent appointment on record is 05 Dec 2023 at Norbix Pharma Private Limited.
Sunil Malik held 1 earlier board appointment: Relward Pharma Private Limited (Director, 18 Nov 2020 to 21 Jan 2026).
The current boards of Sunil Malik's companies include Ankit Raj (Norbix Pharma Private Limited), Gurpreet Singh (Norbix Pharma Private Limited), Sumit Kumar Pandey (Norbix Pharma Private Limited).